I Like thisEquine Gastric Ulcer Syndrome. Solagran and...

I Like this
Equine Gastric Ulcer Syndrome. Solagran and BioProspect have been approached
recently by thoroughbred owners from the Middle East interested in the potential of
Bioeffectives A and I to be used in combination as a treatment for EGUS, a condition
endemic in the racing industry worldwide.
If adopted, this could translate into a demand of 7g of Bioeffective A per day per animal
(equivalent to more than two packs of Bioeffective A 320 every three days)
􀂉 Medicated Toothpaste. The Pasteur Institute has recommended that Bioeffective A be
registered as a BANA in Russia later this year for inclusion in toothpaste and chewing gum
as a means of preventing the spread of H.pylori
The additional demand for Bioeffective A arising from this initiative would be significant